Literature DB >> 14993353

LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing.

Yuan Zhang1, David J Mangelsdorf.   

Abstract

Cholesterol homeostasis is maintained by a regulatory network that controls both the acquisition and elimination of cholesterol. Recent studies have elucidated a mechanism by which cholesterol metabolism is transcriptionally regulated by several classes of orphan nuclear receptors. In particular, the liver X receptors, LXRalpha and LXRbeta, appear to serve as key sensors of intracellular sterol levels by regulating the expression of genes that control cholesterol absorption, storage, transport, and elimination. LXRs are also involved in fatty acid metabolism by their ability to increase the expression of sterol regulatory element-binding protein 1c (SREBP-1c). These findings define LXRs as potential therapeutic targets for the treatment of lipid disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14993353     DOI: 10.1124/mi.2.2.78

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  12 in total

Review 1.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

2.  Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression.

Authors:  Chiara Gabbi; Hyun-Jin Kim; Kjell Hultenby; Didier Bouton; Gudrun Toresson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

3.  Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.

Authors:  Yupanqui A Caldas; Hector Giral; Michael A Cortázar; Eileen Sutherland; Kayo Okamura; Judith Blaine; Victor Sorribas; Hermann Koepsell; Moshe Levi
Journal:  Kidney Int       Date:  2011-06-15       Impact factor: 10.612

4.  Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis.

Authors:  Yasuaki Takeyama; Kazuko Kanegae; Shinjiro Inomata; Kazuhide Takata; Takashi Tanaka; Shu-Ichi Ueda; Keiji Yokoyama; Daisuke Morihara; Shinya Nishizawa; Akira Anan; Makoto Irie; Kaoru Iwata; Satoshi Shakado; Tetsuro Sohda; Shotaro Sakisaka
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

5.  Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity.

Authors:  Michael B Fessler
Journal:  Curr Signal Transduct Ther       Date:  2008-05-01

Review 6.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

7.  Cloning and Characterization of Lxr and Srebp1, and Their Potential Roles in Regulation of LC-PUFA Biosynthesis in Rabbitfish Siganus canaliculatus.

Authors:  Qinghao Zhang; Cuihong You; Fang Liu; Wendi Zhu; Shuqi Wang; Dizhi Xie; Óscar Monroig; Douglas R Tocher; Yuanyou Li
Journal:  Lipids       Date:  2016-07-27       Impact factor: 1.880

8.  Lipid and Cholesterol Homeostasis after Arsenic Exposure and Antibiotic Treatment in Mice: Potential Role of the Microbiota.

Authors:  Liang Chi; Yunjia Lai; Pengcheng Tu; Chih-Wei Liu; Jingchuan Xue; Hongyu Ru; Kun Lu
Journal:  Environ Health Perspect       Date:  2019-09-18       Impact factor: 9.031

9.  Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice.

Authors:  Jian Liu; Haoyue Huang; Sheng Shi; Xu Wang; Yunsheng Yu; Yanqiu Hu; Jiacheng Sun; Chuanlu Ren; Junjie Yang; Zhenya Shen
Journal:  Exp Ther Med       Date:  2018-09-04       Impact factor: 2.447

10.  Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.

Authors:  Kathleen Smoak; Jennifer Madenspacher; Samithamby Jeyaseelan; Belinda Williams; Darlene Dixon; Katie R Poch; Jerry A Nick; G Scott Worthen; Michael B Fessler
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.